Pain in Special Populations-A Guide to Pain Management and Safe Opioid Prescribing
Disclosures Heading link
Pharmacist Academic Detailer Speaker:
Please visit https://academicdetail.pharmacy.uic.edu/speakers_disclosures/ for a list of potential speakers.
Disclosure (s): For the latest disclosure information, please visit https://academicdetail.pharmacy.uic.edu/speakers_disclosures/
The speakers, planning committee members, and reviewers who contributed to this program have no relevant financial conflicts of interest to disclose unless noted below.
- Speaker, Dr. Chintan Patel has stock ownership with companies: Abbvie, Caladrius Biosciences Inc, Clover Health Investments Corp, Diffusion Pharmaceuticals Inc, Dynavax Technologies Corp, Gilead Sciences Inc, Glasko Smith Kline, Haleon, lmmunocellular Therapeutics, Motus GI Holdings Inc, Novabay Pharmaceuticals Inc, Novavax Inc, Ocugen Inc, Pfizer Inc, Protalix Biotherapeutics Inc, PuImatrix Inc, Quince Therapeutics Inc, Salarius Pharmaceuticals inc, Synthetic Biologics Inc, and Vaccinex Inc.
- Speaker, Dr. Stewart Chung has stock ownership with companies Takeda and Silo Pharmaceutical.
- Speaker, Dr. Judith Jakuszewski has stock ownership with Pfizer.
All relevant financial relationships listed for the above speakers have been mitigated.
Type of Activity: Knowledge-based
Learning Objectives Heading link
Learning Objectives:
- Discuss the pain management of special populations including pregnancy, adolescent use, use in incarcerated individuals or the military
- Discuss the current recommended pain management treatment for pregnant and breastfeeding women
- Discuss the current recommended pain management of children and adolescents
Activity Information Heading link
Target Audience: | Nurses | Fee: | Free |
Release Date: | April 11, 2023 | Expiration Date: | February 17, 2024 |
Estimated time to complete: | 0.5 hours | CNE: | 0.5 contact hours of CNE |
Go to activity
Credit Heading link
How to Earn Credit:
Participants must complete the activity as described above in the Continuing Education Statements by attending the entire academic detailing session, completing a pre and post-test, and successfully submitting an activity evaluation. A certificate of completion or uploading of CPE credits to CPE Monitor will be issued after all requirements as described are completed.
Hardware/Software and Internet Requirements can be found at https://cemedicine.uic.edu/online-activities/requirements/.
Provider Contact Information:
For general information please call the Office of Continuing Education and Meeting Services toll-free at (866) PHARM-CE (866-742-7623) or send an e-mail to: pharmce@uic.edu. Copyright © 2023– The Board of Trustees of the University of Illinois. All rights reserved. Reproduction in whole or in part without permission is prohibited. Privacy Policy